Specialty Pharmacies Become Essential for Health Systems in 2026

The year 2026 has started on a challenging note for U.S. Health systems. According to Becker’s Hospital Review, which analyzed data from over 1,900 hospitals, operating margins plummeted to -0.6% in January, the lowest point in 12 months and a significant drop from 1.3% in December. Total expenses rose by 5.4% year over year, while revenue increased only 3.9%. The biggest driver of these rising costs? Drug expenditures, which surged by 6.8%, making them the fastest-growing non-labor expense.

For health system leaders, these figures are not just numbers; they represent a growing crisis that threatens patient care and financial sustainability. Hospitals with fewer than 100 beds and those with more than 500 have felt the margin pressure most acutely. The usual strategies for improving efficiency, optimizing labor, supply chain management, and volume recovery, are either already exhausted or facing their own challenges.

Shifting Patient Demographics Highlight New Challenges

Beneath these headline figures lies a more nuanced story. While overall patient demand softened in January, with inpatient admissions falling by 2.4% and outpatient visits declining by 2.5%, the types of patients seeking care are changing. Genetics-related volumes grew by 12.8%, hematology cases increased by 12.2%, and cancer cases rose by 10.6%. These specialties, known for their high drug intensity, complex reimbursement structures, and demanding clinical requirements, are expanding precisely when health systems can least afford it.

The growing number of patients with complex, chronic conditions who require specialty medications is putting a strain on existing pharmacy operations. Many hospitals lack the infrastructure to manage these drugs effectively, leading to inefficiencies, higher costs, and potential gaps in patient care. This mismatch between patient needs and operational capabilities is a critical issue that health system leaders must address.

One solution gaining traction is the integration of specialty pharmacies into hospital systems. These pharmacies are designed to handle the unique challenges of specialty medications, including complex dosing regimens, strict storage requirements, and intricate insurance processes. By bringing these services in-house, hospitals can improve patient outcomes, control costs, and retain more revenue within their own systems.

The benefits of integrating specialty pharmacies extend beyond financial stability. They also enhance patient care by ensuring that patients receive the right medications at the right time, reducing the risk of adverse events and improving treatment adherence. For example, an AI program in Utah has sparked a debate about the role of technology in healthcare, but it also highlights how advanced tools can support pharmacists in managing complex cases more effectively.

Why It Matters

The integration of specialty pharmacies is not just a financial imperative; it's a matter of patient safety and quality of care. As the demand for specialized medical services continues to grow, health systems must adapt their infrastructure to meet these needs. Failure to do so could result in higher costs, reduced access to essential treatments, and poorer patient outcomes.

By investing in specialty pharmacy capabilities, health systems can ensure that they are equipped to handle the evolving landscape of healthcare. This investment is not just a short-term fix but a long-term strategy for sustainability and excellence in patient care. As the debate around AI and other technological advancements continues, one thing is clear: the future of healthcare requires a robust, adaptive infrastructure that puts patients at the center of every decision.